These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1612490)

  • 1. Computed tomography in predicting gall stone solubility: a prospective trial.
    Caroli A; Del Favero G; Di Mario F; Spigariol F; Scalon P; Meggiato T; Zambelli C; Naccarato R
    Gut; 1992 May; 33(5):698-700. PubMed ID: 1612490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy with oral ursodeoxycholic and chenodeoxycholic acids: pretreatment computed tomography of the gall bladder improves gall stone dissolution efficacy.
    Walters JR; Hood KA; Gleeson D; Ellul JP; Keightley A; Murphy GM; Dowling RH
    Gut; 1992 Mar; 33(3):375-80. PubMed ID: 1568659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is computed tomography a reliable indicator of stone solubility?
    Caroli A; Del Favero G; Di Mario F; Spigariol F; Naccarato R
    Ital J Gastroenterol; 1990 Apr; 22(2):82. PubMed ID: 2131937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Composition of gall bladder stones associated with octreotide: response to oral ursodeoxycholic acid.
    Hussaini SH; Pereira SP; Murphy GM; Kennedy C; Wass JA; Besser GM; Dowling RH
    Gut; 1995 Jan; 36(1):126-32. PubMed ID: 7890216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Computed X-ray tomography in predicting the efficacy of oral cholelithiasis with bile acids].
    Fu XB
    Zhonghua Yi Xue Za Zhi; 1993 Feb; 73(2):81-4, 126. PubMed ID: 8391902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gall stone recurrence and its prevention: the British/Belgian Gall Stone Study Group's post-dissolution trial.
    Hood KA; Gleeson D; Ruppin DC; Dowling RH
    Gut; 1993 Sep; 34(9):1277-88. PubMed ID: 8406169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral dissolution therapy for cholelithiasis: mix and match.
    Phillips RS; Barkin JS
    Am J Gastroenterol; 1990 Nov; 85(11):1532-3. PubMed ID: 2239886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ursodeoxycholic acid for the dissolution of radiolucent gall bladder stones.
    Neligan P; Bateson MC; Trash DB; Ross PE; Bouchier IA
    Digestion; 1983; 28(4):225-33. PubMed ID: 6671484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computed tomography in predicting the efficacy of oral cholelitholysis with bile acids.
    Fu XB; Liu JY; Liu GN; Shao XM; Zhou XS
    Chin Med J (Engl); 1993 Oct; 106(10):734-8. PubMed ID: 8033604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computed tomography in the identification of gallstones likely to respond to UDCA.
    Caroli A; Di Mario F; Spigariol F; Meggiato T; Scalon P; Basso D; Del Favero G
    Ital J Gastroenterol; 1992 Oct; 24(8):466-7. PubMed ID: 1421451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of computerized tomography in the densitometric assessment of lithiasis of the gallbladder].
    Polverosi R; Sbeghen R; Zambelli C; Caracciolo F; Spigariol F; Caroli A
    Radiol Med; 1992 Oct; 84(4):387-92. PubMed ID: 1455020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gall-stone dissolution treatment using cholelitholytic bile acids: experience with 24 patients.
    van Erpecum KJ; van Berge Henegouwen GP; van der Werf SD
    Neth J Med; 1989 Feb; 34(1-2):3-9. PubMed ID: 2644556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gall stone disease without gall stones--bile acid and bile lipid metabolism after complete gall stone dissolution.
    Ruppin DC; Murphy GM; Dowling RH
    Gut; 1986 May; 27(5):559-66. PubMed ID: 3699565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gallstone dissolution after 6 months of ursodeoxycholic acid (UDCA): effectiveness of different doses.
    Podda M; Zuin M; Carulli N; Ponz de Leon M; Dioguardi ML
    J Int Med Res; 1982; 10(1):59-63. PubMed ID: 7060825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gall stone dissolving agents.
    Bouchier IA
    Br Med J (Clin Res Ed); 1983 Mar; 286(6367):778-80. PubMed ID: 6402249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of radiolucent gallstones by computed tomography for in vivo estimation of stone components.
    Rambow A; Staritz M; Wosiewitz U; Mildenburger P; Thelen M; Meyer zum Büschenfelde KH
    Eur J Clin Invest; 1990 Aug; 20(4):475-8. PubMed ID: 2121509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracorporeal shock wave lithotripsy: elimination of densely calcified gallstones and gallstones with calcified rims.
    Uchiyama F; Otsuka K; Kai M; Maeda Y; Higashi S; Setoguchi T
    Eur J Gastroenterol Hepatol; 2000 Mar; 12(3):305-12. PubMed ID: 10750651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimum bile acid treatment for rapid gall stone dissolution.
    Jazrawi RP; Pigozzi MG; Galatola G; Lanzini A; Northfield TC
    Gut; 1992 Mar; 33(3):381-6. PubMed ID: 1568660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gall stone pulverisation strategy in patients treated with extracorporeal lithotripsy and follow up results of maintenance treatment with ursodeoxycholic acid.
    Boscaini M; Piccinni-Leopardi M; Andreotti F; Montori A
    Gut; 1994 Jan; 35(1):117-21. PubMed ID: 8307431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective, multicenter study on value of computerized tomography (CT) in gallstone disease in predicting response to bile acid therapy.
    Petroni ML; Jazrawi RP; Grundy A; Lanzini A; Pigozzi MG; Biasio A; Heaton KW; Virjee J; Northfield TC
    Dig Dis Sci; 1995 Sep; 40(9):1956-62. PubMed ID: 7555450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.